World Journal of Traditional Chinese Medicine

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 5  |  Issue : 2  |  Page : 71--80

Standardized Xin-Ke-Shu tablets improves the disturbances of lipid, energy, and amino acid metabolism in a rabbit model of atherosclerosis


Yong Yang, Jing-Bo Peng, Meng Yu, Hong-Mei Jia, Hong-Wu Zhang, Zhong-Mei Zou 
 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Correspondence Address:
Zhong-Mei Zou
No. 151, Malianwa North Road, Haidian District, Beijing 100193
China

Objective: Xin-Ke-Shu (XKS), a patent drug, used to treat coronary artery diseases in China for many years. Previous research indicates that XKS has similar therapeutic effect as atorvastatin (AS) against atherosclerotic in rabbits. However, biochemical assays demonstrate that XKS could have a different therapeutic mechanism from AS. The aim of this study is to explore the mechanism of XKS therapeutic effect, especially those different from AS. Materials and Methods:1H nuclear magnetic resonance-based metabonomics were applied to profile the low-molecular-weight polar metabolites in the plasma of rabbits fed a high cholesterol diet. Results: Seven of the eleven pathological biomarkers related to atherosclerosis in rabbits were mediated by XKS treatment, namely low-density lipoprotein/very-low-density lipoprotein (LDL/VLDL), lactate, citrate, phosphatidylcholine, glutamine, creatinine, and methionine, as well as two characteristic metabolites of pyruvate and α-glucose. These metabolites involved lipid, energy, and amino acid metabolism, and all could be considered XKS treatment targets. However, AS only affected the metabolic disorders associated with LDL/VLDL and phosphatidylcholine, which is mainly target lipid metabolism. Conclusions: This study indicates that the anti-atherosclerosis effects of AS mainly involve reducing blood–lipid levels, but those of XKS involve a multitargeted activity.


How to cite this article:
Yang Y, Peng JB, Yu M, Jia HM, Zhang HW, Zou ZM. Standardized Xin-Ke-Shu tablets improves the disturbances of lipid, energy, and amino acid metabolism in a rabbit model of atherosclerosis.World J Tradit Chin Med 2019;5:71-80


How to cite this URL:
Yang Y, Peng JB, Yu M, Jia HM, Zhang HW, Zou ZM. Standardized Xin-Ke-Shu tablets improves the disturbances of lipid, energy, and amino acid metabolism in a rabbit model of atherosclerosis. World J Tradit Chin Med [serial online] 2019 [cited 2020 Apr 2 ];5:71-80
Available from: http://www.wjtcm.net/article.asp?issn=2311-8571;year=2019;volume=5;issue=2;spage=71;epage=80;aulast=Yang;type=0